Omlonti is a Ophthalmic Solution/ Drops in the Human Prescription Drug category. It is labeled and distributed by Santen Incorporated. The primary component is Omidenepag Isopropyl.
| Product ID | 65086-002_e9ecbd7e-ef67-5759-e053-2995a90ab5ee |
| NDC | 65086-002 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Omlonti |
| Generic Name | Omidenepag Isopropyl |
| Dosage Form | Solution/ Drops |
| Route of Administration | OPHTHALMIC |
| Marketing Start Date | 2022-09-23 |
| Marketing Category | NDA / |
| Application Number | NDA215092 |
| Labeler Name | Santen Incorporated |
| Substance Name | OMIDENEPAG ISOPROPYL |
| Active Ingredient Strength | 0 mg/mL |
| NDC Exclude Flag | N |
| Listing Certified Through | 2023-12-31 |
| Marketing Start Date | 2022-09-23 |
| NDC Exclude Flag | N |
| Sample Package? | N |
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
![]() OMLONTI 79227958 5640040 Live/Registered |
Santen Pharmaceutical Co., Ltd. 2017-11-13 |